Enantioselective Drug Recognition by Drug Transporters

Molecules. 2018 Nov 22;23(12):3062. doi: 10.3390/molecules23123062.

Abstract

Drug transporters mediate the absorption, tissue distribution, and excretion of drugs. The cDNAs of P-glycoprotein, multidrug resistance proteins (MRPs/ABCC), breast cancer resistance protein (BCRP/ABCG2), peptide transporters (PEPTs/SLC15), proton-coupled folate transporters (PCFT/SLC46A1), organic anion transporting polypeptides (OATPs/SLCO), organic anion transporters (OATs/SLC22), organic cation transporters (OCTs/SLC22), and multidrug and toxin extrusions (MATEs/SLC47) have been isolated, and their functions have been elucidated. Enantioselectivity has been demonstrated in the pharmacokinetics and efficacy of drugs, and is important for elucidating the relationship with recognition of drugs by drug transporters from a chiral aspect. Enantioselectivity in the transport of drugs by drug transporters and the inhibitory effects of drugs on drug transporters has been summarized in this review.

Keywords: drug transporter; enantioselectivity; inhibition; pharmacokinetics; transport.

Publication types

  • Review

MeSH terms

  • Animals
  • Humans
  • Membrane Transport Proteins / chemistry
  • Membrane Transport Proteins / metabolism*
  • Molecular Structure
  • Pharmaceutical Preparations / chemistry*
  • Pharmacokinetics
  • Stereoisomerism
  • Structure-Activity Relationship
  • Tissue Distribution

Substances

  • Membrane Transport Proteins
  • Pharmaceutical Preparations